Paul Matteis

Stock Analyst at Stifel

(2.33)
# 2,629
Out of 5,182 analysts
131
Total ratings
43.18%
Success rate
-0.05%
Average return

Stocks Rated by Paul Matteis

Definium Therapeutics
Apr 17, 2026
Initiates: Buy
Price Target: $30
Current: $21.27
Upside: +41.04%
Immunic
Apr 17, 2026
Initiates: Buy
Price Target: $25
Current: $10.75
Upside: +132.56%
LB Pharmaceuticals
Mar 27, 2026
Maintains: Buy
Price Target: $35$40
Current: $31.38
Upside: +27.47%
KalVista Pharmaceuticals
Mar 26, 2026
Maintains: Buy
Price Target: $39$42
Current: $19.24
Upside: +118.30%
Ionis Pharmaceuticals
Feb 26, 2026
Maintains: Hold
Price Target: $73$77
Current: $71.78
Upside: +7.27%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Hold
Price Target: $25$24
Current: $22.67
Upside: +5.87%
Vertex Pharmaceuticals
Feb 13, 2026
Maintains: Hold
Price Target: $445$466
Current: $430.14
Upside: +8.34%
uniQure
Dec 11, 2025
Maintains: Buy
Price Target: $50$40
Current: $18.05
Upside: +121.61%
Neurocrine Biosciences
Dec 11, 2025
Maintains: Buy
Price Target: $183$188
Current: $128.12
Upside: +46.74%
Dyne Therapeutics
Dec 11, 2025
Maintains: Buy
Price Target: $36$39
Current: $18.16
Upside: +114.76%
Maintains: Buy
Price Target: $495$508
Current: $302.11
Upside: +68.15%
Initiates: Buy
Price Target: $28
Current: $30.31
Upside: -7.62%
Maintains: Hold
Price Target: $2$3
Current: $2.25
Upside: +33.33%
Downgrades: Hold
Price Target: $73$61
Current: $53.30
Upside: +14.45%
Upgrades: Buy
Price Target: $144$202
Current: $183.38
Upside: +10.15%
Maintains: Buy
Price Target: $9$12
Current: $1.58
Upside: +659.49%
Maintains: Buy
Price Target: $78$94
Current: $84.18
Upside: +11.67%
Initiates: Buy
Price Target: $32
Current: $39.59
Upside: -19.17%
Maintains: Buy
Price Target: $18$32
Current: $19.85
Upside: +61.21%
Initiates: Buy
Price Target: $11
Current: $8.44
Upside: +30.33%
Downgrades: Hold
Price Target: $4
Current: $2.39
Upside: +67.36%
Maintains: Buy
Price Target: $32$10
Current: $24.47
Upside: -59.13%
Maintains: Buy
Price Target: $44$60
Current: $27.45
Upside: +118.58%
Upgrades: Buy
Price Target: $25$36
Current: $34.14
Upside: +5.45%
Initiates: Buy
Price Target: $35
Current: $33.74
Upside: +3.73%
Initiates: Buy
Price Target: $29
Current: $12.52
Upside: +131.72%
Initiates: Buy
Price Target: $20
Current: $5.81
Upside: +244.23%
Initiates: Buy
Price Target: $12
Current: $0.60
Upside: +1,911.40%
Initiates: Buy
Price Target: $27
Current: $2.46
Upside: +997.56%
Maintains: Outperform
Price Target: $53$64
Current: $7.52
Upside: +751.06%